Keyphrases
Mesenchymal Stem Cells
92%
T Helper 17 (Th17)
23%
Mesenchymal Stromal Cells
19%
T Cells
17%
Systemic Lupus Erythematosus
13%
Human Mesenchymal Stem Cells (hMSCs)
12%
Cell Therapy
12%
Macrophages
11%
Therapeutic Properties
9%
Regulatory T (Treg) Cells
9%
Endometrial Stem Cells
9%
Experimental Autoimmune Encephalomyelitis
9%
Rheumatoid Arthritis
9%
Mitochondrial Transfer
9%
Interleukin-17 (IL-17)
8%
Stem Cell Therapy
8%
Cell-based
7%
Autoimmune Disease
7%
Therapeutic Potential
7%
CD4+
7%
Mesenchymal Stem Cell Therapy
6%
Regulatory T Cells
6%
Rat Model
6%
Rheumatic Heart Disease
6%
Chronic Kidney Disease
6%
Interleukin-33 (IL-33)
6%
Small Extracellular Vesicles
6%
MicroRNA
6%
Th1 Cells
6%
Rheumatic Fever
6%
Mouse Model
6%
Cell-mediated
5%
Immunomodulatory
5%
Immunomodulatory Properties
5%
Exosomes
5%
Heart Failure Patients
5%
Immunosuppressive Properties
5%
FoxP3+
5%
Stem Cells
5%
Systemic Lupus Erythematosus Patient
5%
Metabolic Reprogramming
5%
Immunology and Microbiology
Mesenchymal Stem Cell
100%
Immunosuppressive Drug
23%
Regulatory T Cell
21%
T Cell
17%
Stem Cell
15%
Th17 Cell
14%
Systemic Lupus Erythematosus
13%
Inflammatory Arthritis
13%
Macrophage
12%
T-Helper Cell
11%
CD4
10%
Experimental Autoimmune Encephalomyelitis
9%
Cell Function
8%
Autoimmune Disease
8%
Secretion (Process)
8%
Arthritis
7%
Mouse Model
7%
Th1 Cell
7%
Immunity
7%
Rat Model
6%
Cytokine
6%
Interleukin 6
6%
Immunocompetent Cell
5%
Immune System
5%
Bone Marrow Derived Mesenchymal Stem Cell
5%
Umbilical Cord
5%
Target Cell
5%
Zebra Fish
5%